THROMBOLOGIC ApS is a Danish APS based in København K, operating in the Forskning og eksperimentel udvikling indenfor bioteknologi sector. Incorporated in 2009, the company reported a gross profit of -DKK 2.9m in its latest annual filing.
EBITDA margin (of gross profit) 104.4 %
Solidity ratio Equity ÷ Total assets × 100 Among the 10% lowest rated companies in the industry
2012 2012
Liquidity ratio Current assets ÷ Short-term debt Among the 10% highest rated companies in the industry
2012 2012
Return on assets (ROA) Net profit ÷ Total assets × 100 Among the 10% lowest rated companies in the industry
2012 2012
EBITDA — year on year DKK thousands 0 -944 -1888 -2832 -3776 2012: -3032 -3032 2012
Key figures Annual report 2012 Gross profit -2.9M DKK — EBITDA -3M DKK — Net profit -2.8M DKK — Total assets 4.2M DKK — Equity -1.3M DKK — Employees — —
Legal name
THROMBOLOGIC ApS
Founded
8 October 2009 · 16 years
Financial year
January – December
Signatory rights
Selskabet tegnes af likvidator.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Explore Financial development In its most recent annual report (2012), THROMBOLOGIC ApS reported a gross profit of -DKK 2.9m. The bottom line showed a net loss of DKK 2.8m.
At the end of 2012, current assets covered short-term debt 28.4 times.
Frequently asked questions What is the CVR number of THROMBOLOGIC ApS? THROMBOLOGIC ApS is registered with CVR / Virk under CVR 32299814.
What is the gross profit of THROMBOLOGIC ApS? THROMBOLOGIC ApS reported a gross profit of -DKK 2.9m in 2012.
Where is THROMBOLOGIC ApS headquartered? THROMBOLOGIC ApS's registered address is Ny Vestergade 7D.
